Inmune Bio, Inc. (INMB) stock
INMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.03+0.07 (+7.29%)
Close on Nov 18, 2026Market cap $28.59MP/E –Yield –
Inmune Bio total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Inmune Bio's total debt was $2.49M at Sep 30, 2024. For fiscal 2023 it was $9.92M, down 32.5% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $9.92M | -32.5% |
| FY2022 | Dec 31, 2022 | $14.70M | +1987.6% |
| FY2021 | Dec 31, 2021 | $704.00K | +340.0% |
| FY2020 | Dec 31, 2020 | $160.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024 | Sep 30, 2024 | $2.49M | +480.0% |
| Q2 FY2024 | Jun 30, 2024 | $4.98M | +975.4% |
| Q1 FY2024 | Mar 31, 2024 | $7.46M | -49.3% |
| Q4 FY2023 | Dec 31, 2023 | $9.92M | +1534.4% |
| Q3 FY2023 | Sep 30, 2023 | $430.00K | -33.3% |
| Q2 FY2023 | Jun 30, 2023 | $463.00K | -32.3% |
| Q4 FY2022 | Dec 31, 2022 | $14.70M | +1987.6% |
| Q3 FY2022 | Sep 30, 2022 | $607.00K | -95.8% |
| Q2 FY2022 | Jun 30, 2022 | $645.00K | +303.1% |
| Q1 FY2022 | Mar 31, 2022 | $684.00K | – |
| Q4 FY2021 | Dec 31, 2021 | $704.00K | – |
| Q2 FY2021 | Jun 30, 2021 | $14.35M | – |
| Q4 FY2020 | Dec 31, 2020 | $160.00K | – |
See a number that looks wrong?